Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-018786

General Counsel sold 385 shares at $0.70 ($268)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-20 Sale : show line 1 in the form −385 $0.70 $268 224,978 D
Open-market sales · 385 sh · avg $0.70 · $268
Loading xslF345X05/ownership.xml…